PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Methanolic extracts of certain cultivars inhibit proinflammatory cytokine production in human promonocytic cell lines [PMID:31607915].
Oily extracts from kernels were investigated for therapeutic effects on oxidative stress and thyroid function in methimazole-induced hypothyroid Wistar rats [PMID:41104254].
Glansreginin A showed moderate antibacterial activity against Staphylococcus aureus and Bacillus anthracis [PMID:37914763]; specific cultivars (Mystry, Surprise, D.34, and A.36) exhibited antibacterial activity against S. aureus [PMID:30274312].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35967790 (2022) — Quantification of Vitamins, Minerals, and Amino Acids in Black Walnut (Juglans nigra). · Frontiers in nutrition
- 2.PMID: 36968185 (2023) — Pan-genome and transcriptome analyses provide insights into genomic variation and differential gene expression profiles related to disease resistance and fatty acid biosynthesis in eastern black walnut (Juglans nigra). · Horticulture research
- 3.PMID: 31607915 (2019) — Black Walnut (Juglans nigra) Extracts Inhibit Proinflammatory Cytokine Production From Lipopolysaccharide-Stimulated Human Promonocytic Cell Line U-937. · Frontiers in pharmacology
- 4.PMID: 24382327 (2014) — Walnut allergens: molecular characterization, detection and clinical relevance. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- 5.PMID: 28265357